alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
3Dshopping.com
                              517 Boccaccio Avenue
                                Venice, CA 90291

                                  May 21, 1999



Brian Smith
10859 Burbank Blvd.
North Hollywood, California

     Re:  Offer letter

Dear Brian:

     3Dshoppping.com ("3D") is pleased to offer you full-time employment with
the title and responsibilities of President, Creative Division. Per our earlier
discussions, this is a salaried position at a starting salary of $10,000.00 per
month, and you will not be compensated for overtime. You will report directly to
me and the 3D board of directors (the "board"), and will have the duties
identified during the interviewing process.

     You will be immediately eligible to participate in all extant 3D employee
benefits. 3D will also create a bonus incentive system (the "bonus plan")
pursuant to which you and your progress will be reviewed each six months for the
purpose, among other things, of determining if you shall receive a bonus based
on your contributions made during that six moth period. Additionally, you will
participate in the 3Dshopping.com 1999 Stock Option Plan at levels that will
from time to time be determined by the board of directors of 3D.

     Employment with 3D is not for a specific term and may be terminated by you
or 3D at any time for any reason, with or without cause. If terminated for no
cause, Smith shall receive six months severance. If any contrary representations
were made to you, they were without authority and are superseded by this offer.
You will be expected, if requested, to sign one or more 3D confidentiality
and/or inventions agreements, and to at all times abide by 3D's policies
regarding safeguarding the proprietary nature of its information. You will also
be required to sign the covenant not to compete which you agreed to in
conjunction with the transaction memorialized by that certain Agreement and Plan
of Reorganization dated as of April 1, 1999 by and among 3D, Design Base Los
Angeles Inc., Todd Hosaka and yourself. Any modification or addition to these
terms must be in writing and signed by you and an authorized signatory of 3D
other than yourself.


<PAGE>
Brian Smith
Offer Letter
May 21, 1999
Page 1


     Please signify your acceptance of the terms of this offer by signing in the
line set forth below.

                                       Very truly yours,

                                       3Dshopping.com


                                       LAWRENCE WEISDORN
                                       -----------------------------------------
                                       Lawrence Weisdorn
                                       President


Reviewed and accepted


BRIAN SMITH
----------------------------------
Brian Smith
Exhibit 10.36 Arena
Pharmaceuticals, Inc. Non-employee
Director Compensation  Equity:  ·Initial Grant
to New Directors:  18,000 options to purchase Arena common
stock. The options vest in equal annual installments over two years.  ·Annual Grant to
Continuing Directors:  12,000 options to purchase Arena common
stock, except for the first annual grant. The annual grants shall be made in
the beginning of each calendar year in accordance with Arenas Stock Option
Grant Policy Statement. The options vest in equal monthly installments over one
year.  ·The first
annual grant to a director shall be reduced pro rata based on the number of
months such director served as a director in the prior year, if any. For
example, if a new director is appointed in August of a particular year,
the director shall receive, in addition to the directors initial grant, 5/12
of the annual equity grant at the same time the annual equity grants are
awarded to the other continuing directors.  ·Duration and
Price of Options: The director options are 10-year options with an
exercise price equal to the fair market value of Arena common stock as
determined under Arenas 2006 Long-Term Incentive Plan, as amended (the LTIP).  A
form of the stock option grant agreement for director option grants under the
LTIP is included as Exhibit 10.2 to the Form 8-K Arena filed with the
Securities and Exchange Commission on August 1, 2006. Arenas Stock Option
Grant Policy Statement includes additional information on option grants,
including the timing of option grants.  Cash:  ·Retainer:  $20,000
annually, paid quarterly, subject to continuing service as a director. If a
director joins the Board after the first quarter of a calendar year, such
directors retainer shall be reduced pro rata on a quarterly basis.  ·Prior to the
beginning of any calendar year or, in the case of a new director, to the extent
permitted, upon joining the Board of Directors, each director can irrevocably
elect to receive 25%, 50%, 75% or 100% of his or her annual cash retainer for
the following, or, in the case of a new director, the remaining portion of the,
calendar year in (i) deferred stock units, or DSUs, on a $1-for-$1 basis, (ii) the
number of options (vesting in approximately equal monthly installments over one
year) determined by dividing three times the retainer amount elected by the
fair market value of Arena common stock, computed at the time the options are
granted, or (iii) a combination of cash, DSUs and options.  ·Meeting Attendance Fee:  ·General: ·In-Person:  $1,000 ·Telephonic:  $500  ·Exceptions: ·Audit Chairperson Meeting
Attendance Fee:


·In-Person:  $3,000 ·Telephonic:  $1,500  ·Other
Chairperson Meeting Attendance Fee: ·In-Person:  $2,000 ·Telephonic:  $1,000  In
addition, the Board of Directors or the Compensation Committee may authorize
additional fees for significant work in informal meetings or for other service
to Arena in the recipients capacity as a director or committee member.Each non-employee director is entitled to
reimbursement for all of such directors reasonable out-of-pocket expenses
incurred in connection with serving on the Board of Directors. 2
John C. ROBINSON, petitioner, v. SOUTH CAROLINA DEPARTMENT OF PROBATION, PAROLE, AND PARDON SERVICES, et al.

No. 17-9415.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
# Official Journal C 48A/24 F

| | ISSN 1725-2423 |
| --- | --- |
| Official Journal
  of the European Union | C 48A |
| | |
| English edition | Information and Notices | Volume 4824 February 2005 |

ISSN 1725-2423

Official Journal

of the European Union

C 48A

English edition

Information and Notices

Volume 4824 February 2005

---

| Notice No | Contents | page |
| --- | --- | --- |
| | III   Notices |
| | European Parliament |
| 2005/C 048A/1 | Recruitment notice PE/92/S — Director (Category A*/AD 14) — Relations with the political groups | 1 |

Notice No

Contents

page

III   Notices

European Parliament

2005/C 048A/1

Recruitment notice PE/92/S — Director (Category A*/AD 14) — Relations with the political groups

1

---

| EN | |
| --- | --- |

EN
Exhibit 32.1   Globalwise Investments, Inc.   CERTIFICATION OF PERIODIC REPORT Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 18 U.S.C. Section 1350  The undersigned executive officer of Globalwise Investments, Inc. certifies pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that:  1. the annual report on Form 10-K of the Company for the year ended December 31, 2008, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and  2. the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.  Date:  March  27, 2009/s/ Donald R. Mayer
Donald R. Mayer
Principal Executive Officer
Principal Financial Officer
**Exhibit 32.2**
**CERTIFICATION**
     Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)and (b) of Section 1350, chapter 63 of title 18, United States Code), theundersigned officer of IPC Holdings, Ltd. (the “Company”), hereby certifies, tosuch officer’s knowledge, that:
The Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2004(the “Report”) fully complies with the requirements of Section 13(a) or 15(d)of the Securities Exchange Act of 1934 and the information contained in theReport fairly presents, in all material respects, the financial condition andresults of operations of the Company.     Dated: July 26, 2004 /s/ John R. Weale     Name: John R. Weale  Title: Chief Financial Officer
The foregoing certification is being furnished solely pursuant to Section 906of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350,chapter 63 of title 18, United States Code) and is not being filed as part ofthe Report.
24
**EXHIBIT10.14**

**OUTSIDEDIRECTOR COMPENSATION**

Annual Retainer*:
| Board Members                           |   | $      | 25,000 |   |
|-----------------------------------------|--------|--------|--------|--------|
| Lead Independent  Director (additional) |   | $      | 15,000 |   |
| Audit Committee  Chairperson            |   | $      | 7,500  |   |
| Compensation  Committee Chairperson     |   | $      | 5,000  |   |
| Corporate  Governance and Nominating    |   |   |   |
| Committee  Chairperson                  |   | $      | 5,000  |   |

 

----

*  Paidquarterly in arrears.

Meeting Fees:
| Board of Directors                             |                            |   |   |
|------------------------------------------------|---------------------------------|--------|--------|
|                                           | Annual offsite regular  meeting |   | $      | 2,500 |   |
|                                           | Regular meeting                 |   | $      | 1,000 |   |
|                                           | Special (telephonic)            |   | $      | 500 |   |
|                                           |                            |   |   |
| Audit Committee                                |                            |   |   |
|                                           | Regular meeting                 |   | $      | 2,500 |   |
|                                           | Special (in person)             |   | $      | 1,000 |   |
|                                           | Special (telephonic)            |   | $      | 750 |   |
|                                           |                            |   |   |
| Compensation Committee                         |                            |   |   |
|                                           | Regular meeting                 |   | $      | 2,000 |   |
|                                           | Special                         |   | $      | 750 |   |
|                                           |                            |   |   |
| Corporate Governance  and Nominating Committee |                            |   |   |
|                                           | Regular meeting                 |   | $      | 2,000 |   |
|                                           | Special                         |   | $      | 750 |   |

 

----
Brandon ERWIN, petitioner, v. FCI COLEMAN-LOW, Warden.

No. 18-7581.

Supreme Court of the United States

May 28, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Deontae THOMAS, petitioner, v. FLORIDA.

No. 18-7314.

Supreme Court of the United States

March 18, 2019.

*1332Petition for writ of certiorari to the District Court of Appeal of Florida, Second District denied.
McKESSON CORPORATION, et al., petitioners, v. TRUE HEALTH CHIROPRACTIC, INC., et al.

No. 18-987.

Supreme Court of the United States

June 24, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed).                    

*Date:*                         June 9, 2022.                    

*Time:*                         1:00 p.m. to 5:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E72, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Hailey Weerts, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3E72, Rockville, MD 20852, (240) 669-5931,                         *weertshp@niaid.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: May 10, 2022.

Tyeshia M. Roberson-Curtis,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-10499 Filed 5-16-22; 8:45 am]

BILLING CODE 4140-01-P
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 24-6415

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

CARLOS ANTOINE BENSON,

Defendant - Appellant.

Appeal from the United States District Court for the Western District of North Carolina, at 

Charlotte. Frank D. Whitney, District Judge. (3:15-cr-00179-FDW-DCK-1; 3:24-cv00341-FDW)

Submitted: September 19, 2024 Decided: September 24, 2024

Before NIEMEYER, RICHARDSON, and HEYTENS, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Carlos Antoine Benson, Appellant Pro Se. 

Unpublished opinions are not binding precedent in this circuit.

USCA4 Appeal: 24-6415 Doc: 6 Filed: 09/24/2024 Pg: 1 of 2
2

PER CURIAM:

Carlos Antoine Benson seeks to appeal the district court’s order dismissing as 

untimely his 28 U.S.C. § 2255 motion. See Whiteside v. United States, 775 F.3d 180, 182-

83 (4th Cir. 2014) (en banc) (explaining that § 2255 motions are subject to one-year statute 

of limitations, running from latest of four commencement dates enumerated in 28 U.S.C. 

§ 2255(f)). The order is not appealable unless a circuit justice or judge issues a certificate 

of appealability. 28 U.S.C. § 2253(c)(1)(B). A certificate of appealability will not issue 

absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. 

§ 2253(c)(2). When, as here, the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural ruling is debatable and that 

the motion states a debatable claim of the denial of a constitutional right. Gonzalez v. 

Thaler, 565 U.S. 134, 140-41 (2012) (citing Slack v. McDaniel, 529 U.S. 473, 484 (2000)).

We have independently reviewed the record and conclude that Benson has not made 

the requisite showing. Accordingly, we deny a certificate of appealability and dismiss the 

appeal. We dispense with oral argument because the facts and legal contentions are 

adequately presented in the materials before this court and argument would not aid the 

decisional process. 

DISMISSED

USCA4 Appeal: 24-6415 Doc: 6 Filed: 09/24/2024 Pg: 2 of 2
El-Sayyid NOSAIR, petitioner, v. UNITED STATES.

No. 18-9111.

Supreme Court of the United States

June 3, 2019.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1669 Introduced in House (IH)]

106th CONGRESS
  1st Session
                                H. R. 1669

 To provide that an annual pay adjustment for Members of Congress may 
not exceed the cost-of-living adjustment in benefits under title II of 
                 the Social Security Act for that year.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 4, 1999

   Mr. Goss introduced the following bill; which was referred to the 
  Committee on Government Reform, and in addition to the Committee on 
House Administration, for a period to be subsequently determined by the 
  Speaker, in each case for consideration of such provisions as fall 
           within the jurisdiction of the committee concerned

_______________________________________________________________________

                                 A BILL

 
 To provide that an annual pay adjustment for Members of Congress may 
not exceed the cost-of-living adjustment in benefits under title II of 
                 the Social Security Act for that year.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. LIMITATION.

    (a) In General.--Section 601(a) of the Legislative Reorganization 
Act of 1946 (2 U.S.C. 31) is amended by adding at the end the 
following:
    ``(3)(A) Notwithstanding any other provision of this subsection, 
rates of pay for positions referred to in paragraph (1) may not be 
increased, as a result of an adjustment scheduled to take effect under 
paragraph (2) in a year, by a percentage greater than the maximum 
percentage allowable for such year.
    ``(B) For purposes of subparagraph (A), the maximum percentage 
allowable for a year is the percentage by which benefits under title II 
of the Social Security Act are increased (if at all) effective December 
1st of the preceding year--
            ``(i) as a result of a determination under section 215(i) 
        of such Act (42 U.S.C. 415(i)); or
            ``(ii) pursuant to a law providing a general benefit 
        increase under such title.''.
    (b) Applicability.--The amendment made by this section shall apply 
with respect to any pay adjustment under section 601(a)(2) of the 
Legislative Reorganization Act of 1946 (2 U.S.C. 31(2)) scheduled to 
take effect after December 31, 2000.
                                 <all>
```
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1698 Introduced in House (IH)]

106th CONGRESS
  1st Session
                                H. R. 1698

  To amend the Federal Meat Inspection Act to provide that a quality 
grade label issued by the Secretary of Agriculture may not be used for 
                 imported meat and meat food products.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 5, 1999

  Mr. Hill of Montana (for himself, Mr. LaTourette, Mrs. Emerson, Mr. 
   McHugh, and Mr. Watkins) introduced the following bill; which was 
                referred to the Committee on Agriculture

_______________________________________________________________________

                                 A BILL

 
  To amend the Federal Meat Inspection Act to provide that a quality 
grade label issued by the Secretary of Agriculture may not be used for 
                 imported meat and meat food products.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``USDA Grade Rescission Act of 1999''.

SEC. 2. QUALITY GRADE LABELING OF IMPORTED MEAT AND MEAT FOOD PRODUCTS.

    Section 1(n) of the Federal Meat Inspection Act (21 U.S.C. 601(n)) 
is amended--
            (1) in paragraph (11), by striking ``or'' at the end;
            (2) in paragraph (12), by striking the period at the end 
        and inserting ``; or''; and
            (3) by adding at the end the following:
            ``(13) if it is an imported carcass, part thereof, meat, or 
        meat food product (including any carcass, part thereof, meat, 
        or meat food product produced from any cattle, sheep, or goats 
        that have not been fed in the United States for at least 90 
        days) and bears a label that indicates a quality grade issued 
        by the Secretary.''.
                                 <all>
```
TEXAS, plaintiff, v. NEW MEXICO and Colorado.

No. 141, Original.

Supreme Court of the United States

June 17, 2019.

Motion of Nathan Boyd Estate, et al. for leave to intervene referred to the Special Master.
Mladen MITROVIC, petitioner, v. UNITED STATES.

No. 18-5407.

Supreme Court of the United States

Oct. 1, 2018.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.